Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sepsis Diagnostics Market, by Method
1.4.2 North America Sepsis Diagnostics Market, by Test Type
1.4.3 North America Sepsis Diagnostics Market, by Pathogen
1.4.4 North America Sepsis Diagnostics Market, by Product
1.4.5 North America Sepsis Diagnostics Market, by End-User
1.4.6 North America Sepsis Diagnostics Market, by Technology
1.4.7 North America Sepsis Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2021, Dec) Leading Players
Chapter 4. North America Sepsis Diagnostics Market by Method
4.1 North America Conventional Market by Country
4.2 North America Automated Market by Country
Chapter 5. North America Sepsis Diagnostics Market by Test Type
5.1 North America Laboratory Tests Market by Country
5.2 North America Point-of-Care Tests Market by Country
Chapter 6. North America Sepsis Diagnostics Market by Pathogen
6.1 North America Bacterial Sepsis Market by Country
6.2 North America Fungal Sepsis Market by Country
6.3 North America Viral Sepsis Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Sepsis Diagnostics Market by Product
7.1 North America Blood Culture Media Market by Country
7.2 North America Assays & Reagents Market by Country
7.3 North America Instruments Market by Country
7.4 North America Software Market by Country
Chapter 8. North America Sepsis Diagnostics Market by End-User
8.1 North America Hospitals & specialty clinics Market by Country
8.2 North America Pathology & Reference Laboratories Market by Country
8.3 North America Research Laboratories & Academic Institutes Market by Country
Chapter 9. North America Sepsis Diagnostics Market by Technology
9.1 North America Blood Culture Market by Country
9.2 North America Immunoassays Market by Country
9.3 North America Molecular Diagnostics Market by Country
9.4 North America Flow Cytometry Market by Country
9.5 North America Microfluidics Market by Country
9.6 North America Biomarkers Market by Country
Chapter 10. North America Sepsis Diagnostics Market by Country
10.1 US Sepsis Diagnostics Market
10.1.1 US Sepsis Diagnostics Market by Method
10.1.2 US Sepsis Diagnostics Market by Test Type
10.1.3 US Sepsis Diagnostics Market by Pathogen
10.1.4 US Sepsis Diagnostics Market by Product
10.1.5 US Sepsis Diagnostics Market by End-User
10.1.6 US Sepsis Diagnostics Market by Technology
10.2 Canada Sepsis Diagnostics Market
10.2.1 Canada Sepsis Diagnostics Market by Method
10.2.2 Canada Sepsis Diagnostics Market by Test Type
10.2.3 Canada Sepsis Diagnostics Market by Pathogen
10.2.4 Canada Sepsis Diagnostics Market by Product
10.2.5 Canada Sepsis Diagnostics Market by End-User
10.2.6 Canada Sepsis Diagnostics Market by Technology
10.3 Mexico Sepsis Diagnostics Market
10.3.1 Mexico Sepsis Diagnostics Market by Method
10.3.2 Mexico Sepsis Diagnostics Market by Test Type
10.3.3 Mexico Sepsis Diagnostics Market by Pathogen
10.3.4 Mexico Sepsis Diagnostics Market by Product
10.3.5 Mexico Sepsis Diagnostics Market by End-User
10.3.6 Mexico Sepsis Diagnostics Market by Technology
10.4 Rest of North America Sepsis Diagnostics Market
10.4.1 Rest of North America Sepsis Diagnostics Market by Method
10.4.2 Rest of North America Sepsis Diagnostics Market by Test Type
10.4.3 Rest of North America Sepsis Diagnostics Market by Pathogen
10.4.4 Rest of North America Sepsis Diagnostics Market by Product
10.4.5 Rest of North America Sepsis Diagnostics Market by End-User
10.4.6 Rest of North America Sepsis Diagnostics Market by Technology
Chapter 11. Company Profiles
11.1 BioMérieux S.A.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Acquisition and Mergers:
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Approvals and Trials:
11.3 Becton, Dickinson and Company
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Product Launches and Product Expansions:
11.4 Abbott Laboratories
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Acquisition and Mergers:
11.5 Thermo Fisher Scientific, Inc.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Approvals and Trials:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 DiaSorin S.p.A. (Luminex Corporation)
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Acquisitions and Mergers:
11.7 Bruker Corporation
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Product Launches and Product Expansions:
11.7.5.2 Acquisition and Mergers:
11.8 Siemens Healthineers AG (Siemens AG)
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental and Regional Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Partnerships, Collaborations, and Agreements:
11.8.5.2 Acquisition and Mergers:
11.9 Danaher Corporation
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.10. Quidel Corporation
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expense
11.10.5 Recent strategies and developments:
11.10.5.1 Acquisition and Mergers:
Unique Offerings 